Science Translational Medicine

Article	Citations
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis	598
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes	351
A tale of two cells: Regulatory T cell–microglia cross-talk in the ischemic brain	345
Increased brain microvascular hemoglobin concentrations in children with cerebral malaria	271
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models	263
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant	260
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens	237
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment	229
Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans	225
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans	221
Antigenic distance between primary and secondary dengue infections correlates with disease risk	202
Advancing beyond the twists and turns of T cell exhaustion in cancer	189
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models	186
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction	184
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome	172
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors	164
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery	162
Evolution of inflammation and immunity in a dengue virus 1 human infection model	162
Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging	161
Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation	161
Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer	152
Engineering CAR-T therapies for autoimmune disease and beyond	151
Stronger regulation of AI in biomedicine	145
AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer	144
Targeting neurotumoral signaling networks in cancer	143

A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine	142
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer	141
Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms	138
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment	138
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies	134
TrkA-mediated sensory innervation of injured mouse tendon supports tendon sheath progenitor cell expansion and tendon repair	134
In vivo gene immunotherapy for cancer	133
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 + T cells	129
Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of HNRNPH2 -related neurodevelopmental disorder	127
MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson’s disease	124
Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation	124
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer	122
TREM1 activation of myeloid cells promotes antitumor immunity	122
Sexually dimorphic differences in angiogenesis markers are associated with brain aging trajectories in humans	122
Translating insights into therapies for Long Covid	121
The pancreatic clock is a key determinant of pancreatic fibrosis progression and exocrine dysfunction	120
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis	119
Development and preclinical validation of 2-deoxy 2-[ 18 F]fluorocellobiose as an Aspergillus -specific PET tracer	118
The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC–derived sensory neurons	118
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa	116
PET imaging of antisense oligonucleotide distribution in rat and nonhuman primate brains using click chemistry	115
Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe	114
Nociceptor-to-macrophage communication through CGRP/RAMP1 signaling drives endometriosis-associated pain and lesion growth in mice	114
Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons	114
NAD + precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunction	113
FcγR-targeted tuftsin clusters rejuvenate macrophages in preclinical sepsis–associated secondary infection	113
Improved control of a prosthetic limb by surgically creating electro-neuromuscular constructs with implanted electrodes	109
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma	108
Chaperone-mediated autophagy supports organ regeneration and fibroblast quiescence in mouse models of fibrosis	105
BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease	102
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis	102
Generating functionally stable and antigen-specific T reg cells from effector T cells for cell therapy of inflammatory diseases	102
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron	101
Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection	101
Actin depolymerization promotes axon regeneration by restoring axonal mitochondrial transport in mouse models of optic neuropathy	100
Molecular hallmarks of hydrocephalus	98
Next-generation CAR T cell therapies for glioblastoma	98
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)	98
Integrating the gut microbiome and pharmacology	97
Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models	96
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease	96
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy	96
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models	95
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment	94
Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders	93
T cell receptor precision editing of regulatory T cells for celiac disease	93
CD23 + IgG1 + memory B cells are poised to switch to pathogenic IgE production in food allergy	93
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis	92
Extracellular BRICK1 drives heart repair after myocardial infarction in mice	92
mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria	92

BDNF Val 66 Met protects oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer	91
Adaptive cognitive control circuit changes associated with problem-solving ability and depression symptom outcomes over 24 months	91
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice	90
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer	90
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease	89
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants	89
Apelin stimulation of the vascular skeletal muscle stem cell niche enhances endogenous repair in dystrophic mice	89
Wastewater surveillance facilitates climate change–resilient pathogen monitoring	89
Harnessing regulatory T cells to establish immune tolerance	89
Transferrin in combination with induction chemotherapy improves outcomes in mouse models of acute myeloid leukemia	86
Clinicogenomic analysis of EGFR -mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation	86
IL-27–mediated hematopoietic dysregulation exacerbates disease severity in severe fever with thrombocytopenia syndrome virus infection	84
Diet shapes the metabolite profile in the intact human ileum, which affects PYY release	84
A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis	83
Obesity and lifespan, a complex tango	83
Short-course combination treatment for experimental chronic Chagas disease	83
Erratum for the Research Article “Phase separation–based HTS identifies cobimetinib as a YAP-TEAD inhibitor that suppresses hyperactivated YAP-induced cancer progression”	82
Anakinra restores immunological misfiring that drives influenza-associated pulmonary aspergillosis	82
A nose for tau	80
Tobacco smoke exposure recruits inflammatory airspace monocytes that establish permissive lung niches for Mycobacterium tuberculosis	80
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria	80
Assessment of cholesterol homeostasis in the living human brain	80
Postoperative adhesions are abrogated by a sustained-release anti-JUN therapeutic in preclinical models	79
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration	79
Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes	79
Cationic nanogel–based nasal therapeutic HPV vaccine prevents the development of cervical cancer	78
The m 6 A demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus	78
Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sites	78
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial	77
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses	77
Erratum for the Research Article “A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer” by A. M. Miller <	76
Myeloid MAS–driven macrophage efferocytosis promotes resolution in ischemia-stressed mouse and human livers	76
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses	75
A cell-penetrant peptide blocking C9ORF72 -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins	75
Multiomic analyses of longitudinal plasma samples identify thromboinflammation endotypes and trajectories in patients with trauma	73
IgE in allergy: It takes two	72
Sex, lean body mass, and cardiac performance	72
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia	72
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria	72
A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice	71
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice	71
Lymphatic disruption drives lung transplant fibrosis through interleukin-1–mediated hyaluronan accumulation	69
Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing	68
Targeting cytokines in inflammatory bowel disease	68
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection	68
Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell–directed therapy for type 1 diabetes prevention	67
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer	67
Inhibiting SLC38A2 lowers blood pressure in rodent models of hypertension	67
Neurotensin receptor 2 agonism attenuates adverse cardiac remodeling in preclinical models	66
Green light analgesia in mice is mediated by visual activation of enkephalinergic neurons in the ventrolateral geniculate nucleus	66
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis	66
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection	65
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases	64
Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice	64
Erratum for the Research Resource “Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy”	63
Synthetic biology–driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer	63
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis	63
Metabolic surgery reduces CRC disease progression through circulating bile acid diversion	63
Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice	62
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19	62
Cancer is embedded in a whole-body neural regulatory network	62
NFIA regulates articular chondrocyte fatty acid metabolism and joint homeostasis	62
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans	62
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis	62
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models	62
Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation	61
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor	61
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis	61
Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice	61
Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy	61
Erratum for the Research Article “Platelet-derived growth factor C signaling is a potential therapeutic target for radiation proctopathy” by W. Lu et al	60
Erratum for the Research Article “Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4” by Y. Ren et al .	60
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis	60
Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging	59
Comment on “A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk”	59
Genetic and structural aspects of amyloid diseases	59
A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos	58
Lowering the HTT1a transcript as an effective therapy for Huntington’s disease in a knockin mouse model	58
Adeno-associated virus gene therapy–mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaques	58
New government drug repurposing programs: Opportunities and uncertainties	58

Design of a neutralizing and protective pan–encephalitic alphavirus receptor decoy protein	58
Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models	58
Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age–related tauopathy and Alzheimer’s disease	58
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice	57
A replicating RNA vaccine protects cynomolgus macaques against lethal clade 2.3.4.4b influenza A H5N1 virus challenge	57
Genipin rescues developmental and degenerative defects in familial dysautonomia models and accelerates axon regeneration	57
Seeking satiety: From signals to solutions	57
Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases	56
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer	56
Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models	56
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity	55
Resident microbes shape the vaginal epithelial glycan landscape	55
Cancer neuroscience: Mechanisms to medicine	54
Neuroinflammation: An astrocyte perspective	54
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6	53
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer	53
Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology	53
Gastric dysfunction in patients with chronic nausea and vomiting syndromes defined by a noninvasive gastric mapping device	52
Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer’s disease	52
Long-term safety and efficacy of intracortical microstimulation in humans	52
In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis	52
Spatial genomics: Mapping the landscape of fibrosis	51
Dietary saturated fatty acids promote lung myeloid cell inflammasome activation and IL-1β–mediated inflammation in mice and humans	51
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers	51
Preexisting immunity to the 2009 pandemic H1N1 virus reduces susceptibility to H5N1 infection and disease in ferrets	51
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma	51
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease	51
Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants	51
Interleukin-2–based therapies in cancer	50
Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit	50
Allergy: Mechanistic insights into new methods of prevention and therapy	50
A peptide immunomodulator activates MST1 to expand and stabilize murine and human regulatory T cells for immune tolerance	50
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease	50
Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models	50
Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppression	49
An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques	49
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem–specific human B cells	49
A prM mutation that attenuates dengue virus replication in human cells enhances midgut infection in mosquitoes	49
Predicting the next round of drugs for Medicare price negotiation	49
Erratum for the Research Article “Boosting systemic absorption of peptides with a bioinspired buccal-stretching patch,” by Z. Luo et al .	49
Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling	49
Response to Comment on “Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases”	49
Provocateurs of autoimmunity within the gut microbiota	49
Where do the pathogens that cause surgical site infections come from?	49
Real-time in vivo analysis of murine β cells reveals autophagic flux defects before onset of autoimmune diabetes	48
Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase	48
Urinary fluorogenic reporters for noninvasive detection and staging of kidney fibrosis	48
Neuronal population activity in the olivocerebellum encodes the frequency of essential tremor in mice and patients	48
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19	48
A mouse model of chronic primary pain that integrates clinically relevant genetic vulnerability, stress, and minor injury	48
Erratum for the Research Article “Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling”	48
Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy	48
Donor-derived regulatory dendritic cell infusion modulates effector CD8+T cell and NK cell responses after liver transplantation	47
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model	47
Chemogenetics identifies separate area 25 brain circuits involved in anhedonia and anxiety in marmosets	47
Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid	47
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity	47
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target	47
An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus	47
Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease	47
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease	47
Learning CNS immunopathology from therapeutic interventions	47
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses	47
Targeting SIRT2 induces MLH1 deficiency and boosts antitumor immunity in preclinical colorectal cancer models	47
Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy	47
Targeting brain hubs of ictal fast ripple activity to reduce seizures in patients with drug-resistant epilepsy	47
Erratum for the Research Article “Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia” by R. Sartori et al .	46
A new chapter in lipid signaling and kidney fibrosis	46
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer	46
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma	46
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human	46
Human inner ear fluid imbalance detected by optical coherence tomography correlates with hearing loss	46
The protein kinase C modulator bryostatin-1 therapeutically targets microglia to attenuate neuroinflammation and promote remyelination	45
Vaccines for a sustainable planet	45
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19	45
Hemodynamic evaluation of biomaterial-based surgery for Tetralogy of Fallot using a biorobotic heart, in silico, and ovine models	45
Bruton’s tyrosine kinase inhibitors rescue neuronal impairment caused by B cell–mediated lymphotoxin-α release	45
CCR5 and CD74 are potential therapeutic targets for necroinflammation in preclinical cholesterol crystal embolism	45
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections	45
Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”	45
Eliminating interactions with the viral Fc receptor improves antibody-mediated protection against neonatal HSV infection in mice	44
A long-term image-derived AI-based risk model for primary prevention of breast cancer in individuals at high risk	44
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings	44
Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis	44
A bioinspired mineralized collagen scaffold promotes enthesis healing and activates Gli1 expression in preclinical models	43
Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease	43
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo	43
Hindbrain octadecaneuropeptide gliotransmission as a therapeutic target for energy balance control without nausea or emesis	43
Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease	43
Increased β 2 -adrenergic signaling promotes fracture healing through callus neovascularization in mice	43
The enhancer landscape predetermines the skeletal regeneration capacity of stromal cells	43
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery	43
Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy	43
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency	43
HIF-2α drives hepatic Kupffer cell death and proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis	43